Benchmark Vaccines Revenue and Competitors
Estimated Revenue & Valuation
- Benchmark Vaccines's estimated annual revenue is currently $3M per year.
- Benchmark Vaccines's estimated revenue per employee is $201,000
Employee Data
- Benchmark Vaccines has 15 Employees.
- Benchmark Vaccines grew their employee count by 0% last year.
Benchmark Vaccines's People
Name | Title | Email/Phone |
---|
Benchmark Vaccines Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $58.9M | 293 | 6% | N/A | N/A |
#2 | $21.1M | 105 | 5% | N/A | N/A |
#3 | $113.4M | 564 | 1% | N/A | N/A |
#4 | $20.9M | 104 | -5% | N/A | N/A |
#5 | $37M | 184 | 9% | N/A | N/A |
#6 | $45.4M | 226 | -24% | N/A | N/A |
#7 | $16.1M | N/A | N/A | N/A | |
#8 | $69.7M | 347 | 0% | N/A | N/A |
#9 | $8M | 40 | 3% | N/A | N/A |
#10 | $25.5M | 127 | 28% | N/A | N/A |
What Is Benchmark Vaccines?
We are a contract manufacturing business focused on animal health vaccines. The scope of services includes process development through to full commercial manufacture of licenced vaccines in our EU GMP approved facility. Our current customers include the animal health divisions of several international pharmaceutical companies.\r\n\r\nPresence / History\r\n\r\nOur manufacturing operation was established in 1977 and was acquired in 2012 by Benchmark Vaccines Ltd (BVL) part of the Benchmark group of companies. We are located in Braintree in the United Kingdom less than 25km from London’s Stansted airport. \r\n\r\nA further BVL manufacturing facility is under development on the Edinburgh Science triangle Biocampus site, this is a 2500 square metre facility 20km from Edinburgh airport in the east of Scotland.\r\n\r\nExperience \r\n\r\nBenchmark Vaccines Ltd has broad experience and expertise in the development, manufacture and quality control of veterinary vaccines to EU GMP across all species including fish. Our operations are performed according to trie℠– 3E principles (ethics, environment and economics) to help create and maintain a sustainable and healthy business.
keywords:N/AN/A
Total Funding
15
Number of Employees
$3M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Benchmark Vaccines News
Daily COVID-19 vaccination totals for all residents in Massachusetts. Fully vaccinated number includes the second doses of Moderna and Pfizer,...
COVID-19 Crisis and Impact on Vaccines Demand. 3.1.2. COVID-19 Impact Benchmark with Previous Crisis. 3.1.3. Impact on Market Value (US$ Mn).
PAHO initiative is an opportunity to accelerate vaccination against COVID-19 ... The Americas region is a global benchmark in immunizations.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 17 | -35% | N/A |
#2 | $1.7M | 19 | -14% | N/A |
#3 | $3.2M | 20 | -23% | N/A |
#4 | N/A | 24 | 0% | N/A |
#5 | $4.3M | 25 | -7% | N/A |